Ligand Pharmaceuticals
LGND
#4143
Rank
โ‚น183.96 B
Marketcap
โ‚น9,736
Share price
0.61%
Change (1 day)
65.35%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น133.34. In 2022 the company made an earnings per share (EPS) of -โ‚น168.16 a decrease over its 2021 EPS that were of โ‚น293.85.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-176.24%
2022-โ‚น168.16-157.23%
2021โ‚น293.85-2571.43%
2020-โ‚น11.89-100.46%
2019โ‚น2,600353.48%
2018โ‚น573.261025%
2017โ‚น50.96-700%
2016-โ‚น8.49-100.87%
2015โ‚น981.761859.32%
2014โ‚น50.115.36%
2013โ‚น47.568.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.61-194.23%
2010-โ‚น44.16548.38%
2009-โ‚น6.81-98.7%
2008-โ‚น524.85-136.52%
2007โ‚น1,437-787.8%
2006-โ‚น208.92-14.58%
2005-โ‚น244.59-21.31%
2004-โ‚น310.83-55.15%
2003-โ‚น693.0081.33%
2002-โ‚น382.172.74%
2001-โ‚น371.98-45.93%
2000-โ‚น687.91-14.56%
1999-โ‚น805.11-45.52%
1998-โ‚น1,478-3.97%
1997-โ‚น1,539132.31%
1996-โ‚น662.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,202 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.57-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น297.31 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น154.71 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น157.96 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น461.09 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น337.16 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น434.83 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,196 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA